Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.

Kizelsztein P, Ovadia H, Garbuzenko O, Sigal A, Barenholz Y.

J Neuroimmunol. 2009 Aug 18;213(1-2):20-5. doi: 10.1016/j.jneuroim.2009.05.019. Epub 2009 Jun 28.

PMID:
19564052
2.

The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release.

Wasserman V, Kizelsztein P, Garbuzenko O, Kohen R, Ovadia H, Tabakman R, Barenholz Y.

Langmuir. 2007 Feb 13;23(4):1937-47. Epub 2007 Jan 9.

PMID:
17279678
3.

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.

Turjeman K, Bavli Y, Kizelsztein P, Schilt Y, Allon N, Katzir TB, Sasson E, Raviv U, Ovadia H, Barenholz Y.

PLoS One. 2015 Jul 6;10(7):e0130442. doi: 10.1371/journal.pone.0130442. eCollection 2015.

4.

Antioxidant therapy in multiple sclerosis.

Mirshafiey A, Mohsenzadegan M.

Immunopharmacol Immunotoxicol. 2009;31(1):13-29. doi: 10.1080/08923970802331943. Review.

PMID:
18763202
5.

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

Calvo P, Gouritin B, Villarroya H, Eclancher F, Giannavola C, Klein C, Andreux JP, Couvreur P.

Eur J Neurosci. 2002 Apr;15(8):1317-26.

PMID:
11994126
6.

Local prevention of oxidative stress in the intestinal epithelium of the rat by adhesive liposomes of superoxide dismutase and tempamine.

Jubeh TT, Antler S, Haupt S, Barenholz Y, Rubinstein A.

Mol Pharm. 2005 Jan-Feb;2(1):2-11.

PMID:
15804172
7.

A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.

Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, Melamed E, Atlas D.

J Neurochem. 2004 Jun;89(5):1241-51.

8.

The effect of Nigella sativa oil against experimental allergic encephalomyelitis via nitric oxide and other oxidative stress parameters.

Ozugurlu F, Sahin S, Idiz N, Akyol O, Ilhan A, Yigitoglu R, Isik B.

Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(3):337-42.

PMID:
16191402
9.

Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.

Avnir Y, Ulmansky R, Wasserman V, Even-Chen S, Broyer M, Barenholz Y, Naparstek Y.

Arthritis Rheum. 2008 Jan;58(1):119-29. doi: 10.1002/art.23230.

10.

The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.

Allameh A, Maleklou N, Zargari M, Sanati MH.

Neurosci Lett. 2008 Jul 4;439(1):111-5. doi: 10.1016/j.neulet.2008.04.053. Epub 2008 Apr 20.

PMID:
18501514
11.

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.

Schmidt J, Metselaar JM, Wauben MH, Toyka KV, Storm G, Gold R.

Brain. 2003 Aug;126(Pt 8):1895-904. Epub 2003 Jun 4.

PMID:
12805101
12.

PEG minocycline-liposomes ameliorate CNS autoimmune disease.

Hu W, Metselaar J, Ben LH, Cravens PD, Singh MP, Frohman EM, Eagar TN, Racke MK, Kieseier BC, Stüve O.

PLoS One. 2009;4(1):e4151. doi: 10.1371/journal.pone.0004151. Epub 2009 Jan 7.

13.

Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD.

Jubeh TT, Nadler-Milbauer M, Barenholz Y, Rubinstein A.

J Drug Target. 2006 Apr;14(3):155-63.

PMID:
16753829
14.

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.

Gilgun-Sherki Y, Melamed E, Offen D.

J Neurol. 2004 Mar;251(3):261-8. Review.

PMID:
15015004
15.

Using PEGylated nano-liposomes to target tissue invaded by a foreign body.

Schroeder A, Sigal A, Turjeman K, Barenholz Y.

J Drug Target. 2008 Aug;16(7):591-5. doi: 10.1080/10611860802228939.

PMID:
18686129
16.

Ultrasound triggered release of cisplatin from liposomes in murine tumors.

Schroeder A, Honen R, Turjeman K, Gabizon A, Kost J, Barenholz Y.

J Control Release. 2009 Jul 1;137(1):63-8. doi: 10.1016/j.jconrel.2009.03.007. Epub 2009 Mar 19.

PMID:
19303426
17.

Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.

Liu Y, Liu J, Tetzlaff W, Paty DW, Cynader MS.

Free Radic Biol Med. 2006 Mar 15;40(6):960-7. Epub 2005 Oct 17.

PMID:
16540391
18.

Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.

Gaillard PJ, Appeldoorn CC, Rip J, Dorland R, van der Pol SM, Kooij G, de Vries HE, Reijerkerk A.

J Control Release. 2012 Dec 28;164(3):364-9. doi: 10.1016/j.jconrel.2012.06.022. Epub 2012 Jun 23.

PMID:
22732475
19.

Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.

Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G.

Anticancer Res. 2009 Jun;29(6):2111-20.

20.

Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE.

Dijkstra S, Kooij G, Verbeek R, van der Pol SM, Amor S, Geisert EE Jr, Dijkstra CD, van Noort JM, Vries HE.

Neurobiol Dis. 2008 Sep;31(3):413-21. doi: 10.1016/j.nbd.2008.05.018. Epub 2008 Jun 5.

PMID:
18586096

Supplemental Content

Support Center